USE OF RADIOPHARMACEUTICALS IN THE DIAGNOSIS OF NEURODEGENERATIVE DISEASES DOI Creative Commons

Anna Tempesta,

Anna Tolomeo,

Azzurra Stefanucci

et al.

European Journal of Medicinal Chemistry Reports, Journal Year: 2024, Volume and Issue: 12, P. 100239 - 100239

Published: Nov. 4, 2024

Language: Английский

Therapeutic Potential of Pectin and Its Derivatives in Chronic Diseases DOI Creative Commons
Anathi Dambuza, Pamela Rungqu, Adebola O. Oyedeji

et al.

Molecules, Journal Year: 2024, Volume and Issue: 29(4), P. 896 - 896

Published: Feb. 18, 2024

Non-communicable diseases (NCDs) are described as a collection of chronic that do not typically develop from an acute infection, have long-term health effects, and frequently require ongoing care therapy. These include heart disease, stroke, cancer, lung neurological diseases, osteoporosis, mental disorders, etc. Known synthetic drugs for the treatment or prevention NCDs become increasingly dangerous over time pose high risks due to side effects such hallucination, attack, liver failure, As result, scientists had look other alternatives natural products known be less detrimental contain useful bioactive compounds. The increasing understanding biological pharmacological significance carbohydrates has helped raise awareness their importance in living systems medicine, given they play numerous roles. For example, pectin been identified class secondary metabolites found medicinal plants may significant role management variety NCDs. Pectin is mainly made homogalacturonan, which linear polymer composed primarily D-galacturonic acid units (at least 65%) linked chain by α-(1,4)-glycosidic linkages. There also modified pectins derivatives improve pectin’s bioavailability. cell walls higher (pteridophytes, angiosperms, gymnosperms), particularly middle lamella plant material. Citrus used various industries. This article compiles information available years about therapeutic different modes extraction, chemistry pectin, potency its derivatives.

Language: Английский

Citations

7

Modulation of cholesterol metabolism with Phytoremedies in Alzheimer’s disease: A comprehensive review DOI
Sushruta Koppula, Nitu L. Wankhede, Shivkumar S. Sammeta

et al.

Ageing Research Reviews, Journal Year: 2024, Volume and Issue: 99, P. 102389 - 102389

Published: June 19, 2024

Language: Английский

Citations

5

Chios mastiha essential oil exhibits antihypertensive, hypolipidemic and anti-obesity effects in metabolically unhealthy adults - a randomized controlled trial DOI Creative Commons
Aristea Gioxari, Charalampia Amerikanou, Evdokia Valsamidou

et al.

Pharmacological Research, Journal Year: 2023, Volume and Issue: 194, P. 106821 - 106821

Published: June 16, 2023

The essential oil of the resinous exudate from Pistacia lentiscus Chios namely Mastiha Essential Oil (CMEO), is a natural volatile rich in monoterpenes α-pinene, β-myrcene, β-pinene. In present randomized controlled trial, we investigated effects CMEO on individuals with abdominal obesity and metabolic abnormalities i.e., dyslipidemia, hypertension, insulin resistance. Eligible patients (N = 94) were randomly assigned to either intervention group, receiving capsules containing 200 mg daily for 3 months adjunct current treatment disorder(s), or control group. Anthropometric measurements, blood markers, quality life (QoL) assessed. Statistical analysis was performed an intention-to-treat basis. A significant improvement lipid profile, triglycerides (p 0.026) low-density lipoprotein 0.05) group versus controls observed. Systolic pressure alanine aminotransferase 0.022) significantly decreased only after intake. Alike, weight 0.02), while mean changes % body fat 0.005) visceral 0.045) different between groups post-intervention. Lower oxidized LDL 0.044) higher adiponectin 0.007) recorded QoL, as assessed by Short Form-12 questionnaire improved compared 0.041 Physical Composite Score, p 0.035 Mental Score). No adverse reported. An anti-obesity effect CMEO, probably attributed modulation inflammatory antioxidant processes, suggested. Conclusively, can be safe effective regulating abnormalities, treatment. (ClinicalTrials.gov. Metabolic Syndrome, ID Number: NCT04785573).

Language: Английский

Citations

12

Dietary supplementation and the role of phytochemicals against the Alzheimer's disease: Focus on polyphenolic compounds DOI Creative Commons
Rayees Ahmad Naik,

Roshni Rajpoot,

Raj Kumar Koiri

et al.

The Journal of Prevention of Alzheimer s Disease, Journal Year: 2025, Volume and Issue: 12(1), P. 100004 - 100004

Published: Jan. 1, 2025

Alzheimer's disease is a complicated, multifaceted, neurodegenerative illness that places an increasing strain on healthcare systems. Due to malfunction and death of nerve cells, the person suffering from (AD) slowly steadily loses their memories, cognitive functions even personality. Although medications may temporarily enhance memory, there are currently no permanent therapies can halt or cure this irreversible process. Nonetheless, fast progress in comprehending cellular molecular abnormalities responsible for neuronal degeneration has increased confidence development viable prevention treatments. All FDA-approved anti-AD have merely symptomatic effects cannot illness. This necessitates pursuit alternate Accumulating data shows systemic neuroinflammation, oxidative stress associated mitochondrial dysfunction play crucial roles etiology AD precede its clinical presentation. Therefore, innovative therapeutic approaches targeting these pathophysiological components being explored aggressively present scenario. Phytochemicals such as resveratrol, curcumin, quercetin, genistein catechins prospective owing capacity alter key pathogenetic pathways, stress, dysfunction. The use new phytochemical delivery strategies would certainly provide possibility solve several issues with standard medicines. In review, phytophenolic compound-based treatment discussed.

Language: Английский

Citations

0

Phytochemicals in plant food waste: innovative insight and implications DOI Creative Commons
Ifrah Usman,

Saima Sana,

Muhammad Afzaal

et al.

Journal of Agriculture and Food Research, Journal Year: 2025, Volume and Issue: unknown, P. 101779 - 101779

Published: Feb. 1, 2025

Language: Английский

Citations

0

Ferulago angulata Extract Protects against Beta-amyloid-induced Memory Impairment Through Modulation of Monoaminoxidase Enzymes in the Rat’s Hippocampus DOI

Niloofar Mashhadi-Sharif,

Maliheh Soodi, Javad Mirnajafi‐Zadeh

et al.

Neurochemical Research, Journal Year: 2025, Volume and Issue: 50(2)

Published: March 5, 2025

Language: Английский

Citations

0

Phyto-nanotechnology: A novel beneficial strategy for Alzheimer's disease therapy DOI

Shayeri Chatterjee Ganguly,

Sk Sangram,

Sayani Paul

et al.

Neurochemistry International, Journal Year: 2024, Volume and Issue: 180, P. 105868 - 105868

Published: Sept. 25, 2024

Language: Английский

Citations

3

Therapeutic potential of flavonoids in the management of obesity-induced Alzheimer’s disease: an overview of preclinical and clinical studies DOI

Sakshi M. Kothawade,

Harpal S. Buttar, Hardeep Singh Tuli

et al.

Naunyn-Schmiedeberg s Archives of Pharmacology, Journal Year: 2023, Volume and Issue: 396(11), P. 2813 - 2830

Published: May 25, 2023

Language: Английский

Citations

8

Monoterpenes and Diterpenes in Combating Alzheimer Disease, Mechanisms, and Clinical Insights: A Comprehensive Review DOI Creative Commons
Elham Hadipour,

Seyedeh Shirin Shahangian,

Farhad Mashayekhi

et al.

Caspian Journal of Neurological Sciences, Journal Year: 2024, Volume and Issue: 10(1), P. 1 - 19

Published: Jan. 1, 2024

Monoterpenes and Diterpenes in Combating Alzheimer Disease, Mechanisms, Clinical Insights: A Comprehensive Review

Language: Английский

Citations

2

Therapeutic Potential of Myrtenal and Its Derivatives—A Review DOI Creative Commons
Stela Dragomanova, Velichka Andonova, Константин П. Волчо

et al.

Life, Journal Year: 2023, Volume and Issue: 13(10), P. 2086 - 2086

Published: Oct. 20, 2023

The investigation of monoterpenes as natural products has gained significant attention in the search for new pharmacological agents due to their ability exhibit a wide range biological activities, including antifungal, antibacterial, antioxidant, anticancer, antispasmodic, hypotensive, and vasodilating properties. In vitro vivo studies reveal antidepressant, anxiolytic, memory-enhancing effects experimental dementia Parkinson’s disease. Chemical modification substances by conjugation with various synthetic components is modern method obtaining biologically active compounds. discovery potential drugs among monoterpene derivatives progressive avenue within pharmacology, offering promising approach therapy diverse pathological conditions. Biologically such monoterpenes, example, borneol, camphor, geraniol, pinene, thymol, are used synthesize compounds analgesic, anti-inflammatory, anticonvulsive, anti-Alzheimer’s, antiparkinsonian, antiviral antibacterial (antituberculosis) Myrtenal perspective monoterpenoid therapeutic fields medicine. Its chemical modifications often lead or more pronounced effects. As an myrtenal established pharmacophore adamantane enables augmentation several its pivotal Myrtenal–adamantane exhibited variety beneficial characteristics, antimicrobial, antiviral, neuroprotective properties, which worth examining detail at length.

Language: Английский

Citations

5